These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22535279)
21. Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro. Broekman MM; Roelofs HM; Wong DR; Kerstholt M; Leijten A; Hoentjen F; Peters WH; Wanten GJ; de Jong DJ Cell Biol Toxicol; 2015 Jun; 31(3):161-71. PubMed ID: 25916701 [TBL] [Abstract][Full Text] [Related]
22. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Kwan LY; Devlin SM; Mirocha JM; Papadakis KA Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898 [TBL] [Abstract][Full Text] [Related]
23. Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A. Schmid BP Toxicology; 1984 May; 31(1):9-21. PubMed ID: 6539517 [TBL] [Abstract][Full Text] [Related]
24. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696 [TBL] [Abstract][Full Text] [Related]
26. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984 [TBL] [Abstract][Full Text] [Related]
27. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Dubinsky MC Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273 [TBL] [Abstract][Full Text] [Related]
28. Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. Vos AC; Wildenberg ME; Arijs I; Duijvestein M; Verhaar AP; de Hertogh G; Vermeire S; Rutgeerts P; van den Brink GR; Hommes DW Inflamm Bowel Dis; 2012 Mar; 18(3):401-8. PubMed ID: 21936028 [TBL] [Abstract][Full Text] [Related]
29. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Lowry PW; Franklin CL; Weaver AL; Pike MG; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ Gut; 2001 Nov; 49(5):665-70. PubMed ID: 11600469 [TBL] [Abstract][Full Text] [Related]
30. Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine. Munnig-Schmidt E; Zhang M; Mulder CJ; Barclay ML Inflamm Bowel Dis; 2018 Mar; 24(4):892-896. PubMed ID: 29522107 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of protein synthesis in human lymphocytes by thiopurines. Smith JL; Forbes IJ Aust J Exp Biol Med Sci; 1970 Jun; 48(3):267-76. PubMed ID: 5271056 [No Abstract] [Full Text] [Related]
32. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
33. Positive pharmacokinetic effect of azathioprine co-medication on infliximab trough levels is dose-dependent. Polakovicova V; Kadleckova B; Lucenicova J; Otottova K; Kinova S; Mikus P; Zelinkova Z Dig Liver Dis; 2019 Aug; 51(8):1112-1116. PubMed ID: 31147215 [TBL] [Abstract][Full Text] [Related]
34. Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality. Caspersen S; Elkjaer M; Riis L; Pedersen N; Mortensen C; Jess T; Sarto P; Hansen TS; Wewer V; Bendtsen F; Moesgaard F; Munkholm P; Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1212-7; quiz 1176. PubMed ID: 18848503 [TBL] [Abstract][Full Text] [Related]
35. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate. Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625 [TBL] [Abstract][Full Text] [Related]
36. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. de Boer NK; Reinisch W; Teml A; van Bodegraven AA; Schwab M; Lukas M; Ochsenkühn T; Petritsch W; Knoflach P; Almer S; van der Merwe SW; Herrlinger KR; Seiderer J; Vogelsang H; Mulder CJ; Digestion; 2006; 73(1):25-31. PubMed ID: 16493198 [TBL] [Abstract][Full Text] [Related]
37. On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients. de Boer NK; Derijks LJ; Gilissen LP; Hommes DW; Engels LG; de-Boer SY; den Hartog G; Hooymans PM; Mäkelburg AB; Westerveld BD; Naber AH; Mulder CJ; de Jong DJ World J Gastroenterol; 2005 Sep; 11(35):5540-4. PubMed ID: 16222751 [TBL] [Abstract][Full Text] [Related]
38. Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease. Ben-Horin S; Waterman M; Kopylov U; Yavzori M; Picard O; Fudim E; Awadie H; Weiss B; Chowers Y Clin Gastroenterol Hepatol; 2013 Apr; 11(4):444-7. PubMed ID: 23103905 [TBL] [Abstract][Full Text] [Related]
39. Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis. Aomori T; Tsuchiya A; Suzuki S; Jibiki A; Otsuka N; Ishioka E; Kaneko Y; Takeuchi T; Nakamura T Pharmazie; 2017 Feb; 72(2):95-97. PubMed ID: 29441860 [TBL] [Abstract][Full Text] [Related]